Integrating Low-Dose Total Body Irradiation into Lymphodepletion Enhances CD19 CAR T-cell Therapy for Large B-cell Lymphoma

Key Points

• Integration of low-dose total body irradiation significantly improves the efficacy of CD19 CAR T-cell therapy.
• The treatment strategy shows improved outcomes for patients with large B-cell lymphoma and prior therapies.
• This approach leverages lymphodepletion to create a more favorable environment for CAR T-cells.
• Additional studies are necessary to fully understand long-term effects and optimize treatment protocols.